Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Huge Global Blood Cancer Market

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Apr 10, 2024 10:04pm

204 Views

Post# 35982566

RE:RE:RE:RE:RE:RE:RE:Huge Global Blood Cancer Market

The fact is that the CR rate for the 12 underdosed patients is not that much lower than for the correctly dosed. And then of course there are the two out of three patients in phase 1 that went, what, 2 years CR or something.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?